Market Tracker

05/22 5:16pm ET

SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

9.44
Delayed Data
As of May 22
 +0.14 / +1.51%
Today’s Change
4.68
Today|||52-Week Range
9.87
+7.76%
Year-to-Date
No recent news for SciClone Pharmaceuticals Inc.

Today’s Trading

Previous close9.30
Today’s open9.32
Day’s range9.27 - 9.51
Volume356,167
Average volume (3 months)420,106
Market cap$468.2M
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+140.00%
Earnings growth (this year)-10.42%
Earnings growth (next 5 years)+14.70%
Revenue growth (last year)+6.09%
P/E ratio16.5
Price/Sales3.33
Price/Book3.04

Competitors

 Today’s
change
Today’s
% change
PETXAratana Therapeutics...-0.10-0.74%
SRNESorrento Therapeutic...-0.27-2.04%
PRQRProQR Therapeutics N...-0.14-0.71%
LBIOLion Biotechnologies...+0.10+0.94%
Data as of 4:14pm ET, 05/22/2015

Financials

Last reporting dateMay 11, 2015
EPS forecast (this quarter)$0.03
Annual revenue (last year)$134.8M
Annual profit (last year)$25.2M
Net profit margin18.70%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Friedhelm Blobel
Chief Financial Officer &
Senior Vice President
Wai-Shun Wilson Cheung
Corporate headquarters
Foster City, California

Forecasts